Navigation Links
BioMS Medical to present at BioCentury Conference
Date:3/24/2008

atements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical Announces 2007 Year End Results
2. BioMS Medical to present at BIO CEO & Investor Conference
3. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
4. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
6. BioMS Medical announces third quarter 2007 results
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medical to present at BioContact 2007
10. BioMS Medical announces its intention to renew a normal course issuer bid
11. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... NDA with FDA in Early to Mid-2009 , , WOOD... Strativa Pharmaceuticals, the proprietary product...NYSE: PRX ) today announced that its development...letion of all pivotal bioequivalence studies for a...tron thin film product is being developed for the ...
(Date:12/2/2008)...., Dec. 2 GeneGo, Inc., the leadin...hat Burnham has become a certified GeneGo Center o...ution-wide access to GeneGo,s MetaCore data analys...ham institute is a world-class biomedical research...ies throughout many departments, including researc...
(Date:12/2/2008)..., Israel, December 2 InSightec Ltd... Magnetic Resonance-guided Focused,Ultrasound (MR...l to be an,effective noninvasive pain-relieving t... (bone metastases). The results of a 31 patient st...als of Surgical Oncology, while data from an,elev...
(Date:12/2/2008)...OLIS, France, December 2 ...unced it has signed an agreement with,DSM for the...drug substance,(or API, active pharmaceutical ing...nal product and the first compound in the,Cycloox...lass of,anti-inflammatory agents, which recently ...
Breaking Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...Roche Discovery Welwyn, 40 Broadwater Road, Welwyn...nt Address: Analytical Sciences, , Syngen...racknell, Berkshire, , RG42 6EY, UK, ...e use of the Bio-Rad PROTEAN Plus Dodeca cell (Fig...ls with preparative protein loads. The Dodeca , ...
... and Carolyn Seggerson 2 , 1 Tech/Aid, , ... 2 Bio-Rad Laboratories, , Inc., 2000 Alf... , Introduction , Running PCR...uming procedure. , It is common to hand c..., A gel of such large size is difficult to...
, , , , back to top
...ction , Amplification of DNA through the...ighly sensitive method capable of copying millions...lecule. 1 Because of the extreme sensitivity of t... previous reactions can result in false positives ...n can be avoided by using positive , disp...
Other Biology Technology:Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 2Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 3Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 4Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 5Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 2Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 3Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 4Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:12/2/2008)...views of nutrition related topics raises unique ch...icine. In a new article, a team of researchers use...s, and limitations of systematic reviews relevant ...he results. , Systematic reviews, also referred...ssessments with pre-specified questions that can b...
(Date:12/1/2008)...- The International Atomic Energy Agency (IAEA) to...eding technique that could bolster efforts aimed a...p. , IAEA scientists use radiation to produce im...imate conditions such as drought or flood, or that...s. Called mutation induction, the technique is saf...
(Date:12/1/2008)...sts around the world may benefit from a powerful n...help them to home in on the parts of proteins most...D, associate professor of pathology and of genetic...ecently launched the novel bioinformatics tool, wh...the role different proteins play in a wide array o...
(Date:12/1/2008)...niversity of Florida, keeper of the world,s shark ...records collection for another toothy marine preda...rum or "saw" that makes it a popular curio item an...orical and cultural icon that is rapidly disappear...urator of both the International Shark Attack File...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 1AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 3AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 4Springer launches new journal in musculoskeletal medicine 7194 1Springer launches new journal in musculoskeletal medicine 7194 2FDA Mulls Cutting Salt in Processed Foods 7192 1FDA Mulls Cutting Salt in Processed Foods 7192 2FDA Mulls Cutting Salt in Processed Foods 7192 3FDA Mulls Cutting Salt in Processed Foods 7192 4Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 1Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 2Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 3Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 4
...mary strategies for regulating its genome is a kin... molecules called microRNAs, or miRNAs. First obse...to inactivate messenger RNA, itself responsible fo... been eager to know more about miRNAs, clearly imp... gone unnoticed for so long. How are they produced...
...lts from a study in Botswana, Harvard School of Pu...h HIV-1 subtype C in resource-poor settings, who r...omparable results to those in the developed world.... infrastructure help ensure this success, accordin...Journal of Acquired Immune Deficiency Syndromes (J...
...thogens, the Chlamydiae know us very, very well. T...ls half a billion years ago by reprogramming cellu...dial infections are responsible for a range of ail...ical pneumonias to chronic severe disorders such a... The Centers for Disease Control says that Chlamyd...
... reported this week in Current Biology, tsunami da...e 2004 Sumatra-Andaman earthquake was occasionally...ly when compared to damage from chronic human misu...tsunami of December 26, 2004, a team of ecologists...tion Society-Indonesia Program, and Syiah Kuala Un...
Other Biology News:Twin molecular scissors link creation of microRNAs with gene-silencing 2Largest computational biology simulation mimics life’s most essential nanomachine 2Chlamydia parasite lives off our fat 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: